A cell‐permeable phosphine‐borane complex delays retinal ganglion cell death after axonal injury through activation of the pro‐survival extracellular signal‐regulated kinases 1/2 pathway
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
J. Neurochem. (2011) 118, 1075–1086. The reactive oxygen species (ROS) superoxide has been recognized as a critical signal triggering retinal ganglion cell (RGC) death after axonal injury. Although the downstream targets of superoxide are unknown, chemical reduction of oxidized sulfhydryls has been shown to be neuroprotective for injured RGCs. On the basis of this, we developed novel phosphine‐borane complex compounds that are cell permeable and highly stable. Here, we report that our lead compound, bis (3‐propionic acid methyl ester) phenylphosphine borane complex 1 (PB1) promotes RGC survival in rat models of optic nerve axotomy and in experimental glaucoma. PB1‐mediated RGC neuroprotection did not correlate with inhibition of stress‐activated protein kinase signaling, including apoptosis stimulating kinase 1 (ASK1), c‐jun NH2‐terminal kinase (JNK) or p38. Instead, PB1 led to a striking increase in retinal BDNF levels and downstream activation of the extracellular signal‐regulated kinases 1/2 (ERK1/2) pathway. Pharmacological inhibition of ERK1/2 entirely blocked RGC neuroprotection induced by PB1. We conclude that PB1 protects damaged RGCs through activation of pro‐survival signals. These data support a potential cross‐talk between redox homeostasis and neurotrophin‐related pathways leading to RGC survival after axonal injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurotrophin signal transduction in the nervous system
Kaplan, D. R., & Miller, F. D. (2000) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00092-1 · Cited by 1,944
Ca2+ Influx Regulates BDNF Transcription by a CREB Family Transcription Factor-Dependent Mechanism
Tao, X., Finkbeiner, S., Arnold, D. B., Shaywitz, A. J., & Greenberg, M. E. (1998) · Neuron · doi:10.1016/s0896-6273(00)81010-7 · Cited by 1,561
Identification of a Signaling Pathway Involved in Calcium Regulation of BDNF Expression
Shieh, P. B., Hu, S.-C., Bobb, K., Timmusk, T., & Ghosh, A. (1998) · Neuron · doi:10.1016/s0896-6273(00)81011-9 · Cited by 693
Kikuchi, M., Tenneti, L., & Lipton, S. A. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-13-05037.2000 · Cited by 197
Bedogni, B., Pani, G., Colavitti, R., Riccio, A., Borrello, S., Murphy, M., Smith, R., Eboli, M. L., & Galeotti, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301089200 · Cited by 124 · cited 1×
“2009) and it is susceptible to redox regulation (Bedogni et al. 2003).”
Background
Cited by
The molecular basis of retinal ganglion cell death in glaucoma
Almasieh, M., Wilson, A. M., Morquette, B., Cueva Vargas, J. L., & Di Polo, A. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.11.002 · Cited by 971
Self-citationGlaucoma as a neurodegenerative disease
Gupta, N., & Yücel, Y. H. (2007) · Current Opinion in Ophthalmology · doi:10.1097/icu.0b013e3280895aea · Cited by 422
An update on toxicology of aluminum phosphide
Moghadamnia, A. A. (2012) · DARU Journal of Pharmaceutical Sciences · doi:10.1186/2008-2231-20-25 · Cited by 158
Neuroprotection in Glaucoma: Animal Models and Clinical Trials
Almasieh, M., & Levin, L. A. (2017) · Annual Review of Vision Science · doi:10.1146/annurev-vision-102016-061422 · Cited by 111
“Typically, soma survival is assessed by retrograde labeling or immunologically identifying RGCs and quantifying their numbers in an animal model of glaucoma after treatment with a neuroprotective agent (Almasieh et al. 2011, WoldeMussie et al. 2001).”
BackgroundSelf-citationNeuroprotection for glaucoma: Requirements for clinical translation
Levin, L. A., Crowe, M. E., Quigley, H. A., Cordeiro, M. F., Donoso, L. A., Liao, Y. J., Libby, R. T., Masland, R. H., Nickells, R. W., Sieving, P. A., et al. (2017) · Experimental Eye Research · doi:10.1016/j.exer.2016.12.005 · Cited by 66
Self-citation
Metadata
- Authors
- Almasieh, M., Lieven, C. J., Levin, L. A., & Di Polo, A.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2011-08-12
- Volume
- 118
- Issue
- 6
- Pages
- 1075-1086
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1488590823
- Cited by
- 49
- References
- 5
- FWCI
- 4.16
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A cell‐permeable phosphine‐borane complex delays retinal ganglion cell death after axonal injury through activation of the pro‐survival extracellular signal‐regulated kinases 1/2 pathway. https://app.cochat.ai/papers/10.1111/j.1471-4159.2011.07382.x
- The paper
- Almasieh, M., Lieven, C. J., Levin, L. A., & Di Polo, A. (2011). A cell‐permeable phosphine‐borane complex delays retinal ganglion cell death after axonal injury through activation of the pro‐survival extracellular signal‐regulated kinases 1/2 pathway. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.2011.07382.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.